Licarbazepine-d4
Licarbazepine-d4 is the deuterium labeled Licarbazepine (HY-108506) . Licarbazepine is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects[1][2].
Product Specifications
CAS Number
[1020719-39-4]
Product Name Alternative
BIA 2-005-d4; GP 47779-d4
UNSPSC
12352005
Hazard Statement
H302-H317-H334-H411
Target
Isotope-Labeled Compounds; Sodium Channel
Type
Isotope-Labeled Compounds
Related Pathways
Membrane Transporter/Ion Channel; Others
Field of Research
Neurological Disease
Solubility
10 mM in DMSO
Smiles
NC(N1C2=CC=CC=C2C(CC3=C([2H])C([2H])=C([2H])C([2H])=C31)O)=O
Molecular Formula
C15H10D4N2O2
Molecular Weight
258.31
Precautions
P261-P273-P280-P304+P340-P391
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SNX29, CT (SNX29, RUNDC2A, Sorting nexin-29, RUN domain-containing protein 2A) (MaxLight 650) discontinued
